Fosun Pharma 复星医药
17 significant filings since 30 May 2026: 2 on share pledge, 5 on guarantee or financial assistance and 4 on pledge released, and 4 other kinds. The latest, on 24 Sep 2026: 复星医药关于控股子公司签订合作与许可协议的公告.
自 30 May 2026 起有 17 份重大公告：share pledge 2 份、guarantee or financial assistance 5 份、pledge released 4 份，另有 4 类。最新一份（24 Sep 2026）：复星医药关于控股子公司签订合作与许可协议的公告。
Price History 价格走势
5 sessions 个交易日, 18 Sep to 24 Sep 2026 · Live one-minute prices · High 最高 ¥23.40 · Low 最低 ¥21.85 · −1.25% on the previous close of ¥23.13No broker reports from the last twelve months are held for this company. Brokers covered 1,186 of the 2,361 SSE listings (50%) over the same period. 近十二个月无本公司研报；同期券商覆盖了 2,361 只 SSE 证券中的 1,186 只（50%）。
| Date 日期 | Broker 券商 | Analyst 分析师 | From 原评级 | To 新评级 | |
|---|---|---|---|---|---|
| 1 Apr 2021 | 群益证券 | 王睿哲 | Buy 买入 | ▼ | Outperform 增持 |
Each broker's rating is compared with its previous report. 每家券商的评级与其上一份研报比较。
Each bar counts the brokers publishing on this company in a quarter. The latest quarter is not yet complete. 每根柱为该季度发布本公司研报的券商数，最近一个季度尚未结束。